Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Q: What does CUSIP 761330109 represent in this 13F holders report?

CUSIP 761330109 is the security identifier for RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q2 2019?

110 institutional investors reported RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q2 2019. Use the holders table for investor-level position and value details.

CUSIP: 761330109

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 104,661,494
Total 13F shares: 43,555,026
Share change: +2,082,014
Total reported value: $564,029,588
Put/Call ratio: 187%
Price per share: $12.97
Number of holders: 110
Value change: +$26,762,019
Number of buys: 62
Number of sells: 40

Quarterly Holders Quick Answers

What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 761330109:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.5%	5,744,134	$90,528,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	3.7%	3,897,850	$61,431,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	3.4%	3,550,138	$55,951,000	—	31 Mar 2019	13F
FRANKLIN RESOURCES INC	13F	Company	3.3%	3,429,256	$54,045,000	—	31 Mar 2019	13F
ArrowMark Colorado Holdings LLC	13F	Company	3.3%	3,409,217	$53,729,000	—	31 Mar 2019	13F
Essex Woodlands Management, Inc.	13F	Company	3.2%	3,342,047	$52,671,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	2.2%	2,292,785	$36,135,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	2%	2,102,700	$33,138,000	—	31 Mar 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	2%	2,041,129	$32,168,000	—	31 Mar 2019	13F
Capital World Investors	13F	Company	1.6%	1,685,000	$26,556,000	—	31 Mar 2019	13F
NovaQuest Capital Management, L.L.C.	13F	Company	1.5%	1,558,426	$24,561,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.86%	902,073	$14,217,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	0.78%	813,443	$12,820,000	—	31 Mar 2019	13F
BAMCO INC /NY/	13F	Company	0.49%	509,200	$8,025,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.48%	498,934	$7,864,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.47%	488,347	$7,696,000	—	31 Mar 2019	13F
Fosun International Ltd	13F	Company	0.45%	472,532	$7,447,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.45%	470,747	$7,417,000	—	31 Mar 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.36%	373,904	$5,893,000	—	31 Mar 2019	13F
Capital International Investors	13F	Company	0.31%	325,000	$5,122,000	—	31 Mar 2019	13F
Sio Capital Management, LLC	13F	Company	0.24%	254,581	$4,012,000	—	31 Mar 2019	13F
S.c.a. Candriam	13F	Individual	0.23%	237,000	$3,735,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.22%	225,381	$3,553,000	—	31 Mar 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.2%	206,451	$3,253,000	—	31 Mar 2019	13F
Rhenman & Partners Asset Management AB	13F	Company	0.18%	193,181	$3,045,000	—	31 Mar 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.13%	135,902	$2,141,000	—	31 Mar 2019	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.11%	117,068	$1,845,000	—	31 Mar 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.11%	117,012	$1,844,000	—	31 Mar 2019	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.11%	114,268	$1,801,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	112,458	$1,772,000	—	31 Mar 2019	13F
MORGAN STANLEY	13F	Company	0.1%	108,216	$1,706,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.1%	107,067	$1,687,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	82,323	$1,297,000	—	31 Mar 2019	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.08%	82,137	$1,294,000	—	31 Mar 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.07%	71,300	$1,124,000	—	31 Mar 2019	13F
Swiss National Bank	13F	Company	0.07%	69,450	$1,095,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	0.06%	64,300	$1,013,000	—	31 Mar 2019	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.06%	64,068	$1,010,000	—	31 Mar 2019	13F
QS Investors, LLC	13F	Company	0.06%	63,161	$996,000	—	31 Mar 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.06%	59,257	$934,000	—	31 Mar 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.05%	57,405	$905,000	—	31 Mar 2019	13F
Quinn Opportunity Partners LLC	13F	Company	0.05%	56,672	$893,000	—	31 Mar 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.05%	51,755	$816,000	—	31 Mar 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.05%	49,124	$774,000	—	31 Mar 2019	13F
MFN Partners Management, LP	13F	Company	0.04%	46,000	$725,000	—	31 Mar 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.03%	36,200	$571,000	—	31 Mar 2019	13F
Cubist Systematic Strategies, LLC	13F	Company	0.03%	35,511	$560,000	—	31 Mar 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.03%	35,199	$555,000	—	31 Mar 2019	13F
BARCLAYS PLC	13F	Company	0.03%	33,477	$529,000	—	31 Mar 2019	13F
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY	13F	Company	0.03%	33,131	$522,000	—	31 Mar 2019	13F

Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q2 2019

As of 30 Jun 2019, Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,555,026 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, ArrowMark Colorado Holdings LLC, BlackRock Inc., FRANKLIN RESOURCES INC, Essex Woodlands Management, Inc., JPMORGAN CHASE & CO, Bank of New York Mellon Corp, VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., and Capital World Investors. This page lists 110 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

108

Q2 2019 holders

110

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.